Bone Marrow-derived Mesenchymal Stem Cells and Chronic Allograft Disease in a Bronchiolitis Obliterans Animal Model.

CONCLUSION: BMSCs modify the course of bronchiolitis obliterans and differentiate into alveolar cells. Endotracheal administration of BMSCs 7 days after the heterotopical tracheal transplant might be considered an effective way to prevent BO in this animal model.
PMID: 31296434 [PubMed - as supplied by publisher]

Source: Archivos de Bronconeumologia - July 7, 2019 Category: Respiratory Medicine Authors: Gómez de Antonio D, Campo-Cañaveral de la Cruz JL, Zurita M, Santos M, González Lois C, Varela de Ugarte A, Vaquero J Tags: Arch Bronconeumol Source Type: research